Special Issue "Vaccine Immunology"
A special issue of Vaccines (ISSN 2076-393X).
Deadline for manuscript submissions: 30 June 2022.
Interests: vaccines; immunology; autoimmunity; cancer; chronic diseases; exercise; mental health; immunotherapy
Special Issues and Collections in MDPI journals
Special Issue in Cancers: Cancer Vaccines: Research and Applications
Special Issue in Vaccines: Therapeutic Approaches for Type 1 and Type 2 Diabetes
Special Issue in Brain Sciences: Advances in Multiple Sclerosis Research—Series I
Special Issue in Vaccines: Multiple Sclerosis and Its Complications: Clinical Trials
Special Issue in Brain Sciences: Advances in Multiple Sclerosis Research—Series II
Special Issue in Vaccines: Vaccines for Infectious and Chronic Diseases
Special Issue in International Journal of Molecular Sciences: Complimentary Medicine for the Treatment of Chronic and Infectious Diseases
Special Issue in Biologics: Anti-SARS-CoV-2/COVID-19 Drugs and Vaccines
Special Issue in Vaccines: Multiple Sclerosis, Complications and Therapeutics 2.0
Extraordinary advances in vaccine technology have led to a detailed understanding of tumor antigens, antigen presentation, innate immunity, cytokine and chemokine pathways, and immunoregulation. As the Guest Editor, I am glad to announce the Special Issue "Vaccine Immunology ". The goal of advancement in vaccine science and technology is to generate a strong immune response to the administered antigens. To achieve this objective with vaccines based on insufficiently immunogenic antigens, adjuvant and other formulation materials are alternatives. This Special Issue covers recent advances in the design of efficient vaccines against emergent infectious pathogens and cancers.
In this Special Issue, we will collect articles from researchers describing new approaches in the field of vaccines against infectious diseases and cancers. Authors are welcome to submit original articles, systematic reviews, short communications, and other article types on related topics. We welcome the submission of manuscripts from outstanding scholars.
Prof. Dr. Vasso Apostolopoulos
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.